Viewing Study NCT06255704


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2025-12-30 @ 2:35 AM
Study NCT ID: NCT06255704
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-13
First Post: 2024-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients
Sponsor: Shanxi Province Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module